A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
Autor: | Tolaney, S.M. *, Najita, J., Sperinde, J., Huang, W., Chen, W.Y., Savoie, J., Fornier, M., Winer, E.P., Bunnell, C., Krop, I.E. |
---|---|
Zdroj: | In Annals of Oncology July 2013 24(7):1841-1847 |
Databáze: | ScienceDirect |
Externí odkaz: |